These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity. Karunakaran KD; Pascale M; Ozana N; Potter K; Pachas GN; Evins AE; Gilman JM Neuropsychopharmacology; 2024 Aug; 49(9):1481-1490. PubMed ID: 38714786 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans. Rabinak CA; Angstadt M; Lyons M; Mori S; Milad MR; Liberzon I; Phan KL Neurobiol Learn Mem; 2014 Sep; 113():125-34. PubMed ID: 24055595 [TBL] [Abstract][Full Text] [Related]
5. Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study. Pelgrim TAD; Ramaekers JG; Wall MB; Freeman TP; Bossong MG Drug Alcohol Depend; 2023 Oct; 251():110925. PubMed ID: 37598453 [TBL] [Abstract][Full Text] [Related]
6. Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis. Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; Kambeitz J; Malhi S; Giampietro V; Williams S; Brammer M; Rubia K; Collier DA; McGuire PK Eur Neuropsychopharmacol; 2015 Jan; 25(1):26-37. PubMed ID: 25532865 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550 [TBL] [Abstract][Full Text] [Related]
8. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. Bossong MG; van Hell HH; Schubart CD; van Saane W; Iseger TA; Jager G; van Osch MJP; Jansma JM; Kahn RS; Boks MP; Ramsey NF Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584 [TBL] [Abstract][Full Text] [Related]
9. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107 [TBL] [Abstract][Full Text] [Related]
10. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890 [TBL] [Abstract][Full Text] [Related]
11. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939 [TBL] [Abstract][Full Text] [Related]
12. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314 [TBL] [Abstract][Full Text] [Related]
13. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC. Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257 [TBL] [Abstract][Full Text] [Related]
14. Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users. van Wel JH; Kuypers KP; Theunissen EL; Toennes SW; Spronk DB; Verkes RJ; Ramaekers JG Br J Pharmacol; 2013 Dec; 170(7):1410-20. PubMed ID: 24106872 [TBL] [Abstract][Full Text] [Related]
15. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Childs E; Lutz JA; de Wit H Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212 [TBL] [Abstract][Full Text] [Related]
16. Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity. Mason NL; Theunissen EL; Hutten NRPW; Tse DHY; Toennes SW; Stiers P; Ramaekers JG Eur Neuropsychopharmacol; 2019 Dec; 29(2):247-256. PubMed ID: 30553697 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic Mediation of Blest-Hopley G; Colizzi M; Prata D; Giampietro V; Brammer M; McGuire P; Bhattacharyya S Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573260 [TBL] [Abstract][Full Text] [Related]
18. Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers. Atakan Z; Bhattacharyya S; Allen P; Martín-Santos R; Crippa JA; Borgwardt SJ; Fusar-Poli P; Seal M; Sallis H; Stahl D; Zuardi AW; Rubia K; McGuire P Psychol Med; 2013 Jun; 43(6):1255-67. PubMed ID: 23020923 [TBL] [Abstract][Full Text] [Related]
19. Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Theunissen EL; Kauert GF; Toennes SW; Moeller MR; Sambeth A; Blanchard MM; Ramaekers JG Psychopharmacology (Berl); 2012 Mar; 220(2):341-50. PubMed ID: 21975580 [TBL] [Abstract][Full Text] [Related]
20. Effect of Δ9-Tetrahydrocannabinol on frontostriatal resting state functional connectivity and subjective euphoric response in healthy young adults. Crane NA; Phan KL Drug Alcohol Depend; 2021 Apr; 221():108565. PubMed ID: 33592558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]